Next Digital Health Blog 3

Massachusetts-based MedTech Company AcuityMD has raised $45 million in a Series B funding round led by ICONIQ Growth, a San Francisco-based venture capital firm seeking to invest in innovative companies operating in healthcare, IT, consumer products, and other sectors. According to the company’s announcement on June 5, 2024, it will utilize the latest capital infusion AcuityMD company will use the series B funding to expand its commercial intelligence platform to medical technology (MedTech) manufacturers.

Rad AI, a pioneer of generative AI solutions in healthcare, has raised $50 million in Series B Funding to expand its AI solutions across health systems globally. According to the company’s announcement on Tuesday, May 7, 2023, the funding round was led by Khosla Ventures, with a significant contribution from WiL(World Innovation Lab). Initial investors Rad AI will use the money raised to expand its generative AI solutions across health systems globally.

Natural Cycles, the developer of the world’s first birth control app, has a $55 million Series C funding round to support new product development, healthcare reimbursement automation, and commercial acceleration. The company’s latest round was led by Lauxera Capital Partners, with significant contributions from Point72 Private Investments and a debt facility from J.P Morgan. Founded

Plenful, a California-based health tech startup providing an AI Workflow automation platform, has raised $17 million in Series A funding to simplify pharmacy and healthcare operations. According to the company's announcement, the funding round, led by TQ Ventures, included participation from Bessemer Venture Partners, Susa Ventures, Mitchell Rales, and existing investors. To date, the company Plenful will use the capital raised to scale and advance its pharmacy operations automation solutions.

In a bold move to address the pressing issue of mental health in the workplace, European startup ifeel has secured a staggering $20 million in Series B funding. The investment, co-led by FinTLV Ventures and Korelya Capital, marks a significant milestone for the company, bringing its total funding to an impressive $40 million since its

BIOPHTA, a France-based preclinical biotech company developing technology solutions for the treatment of eye diseases, has raised €6.5 million (approximately $7 million) in seed funding in the just concluded financing round to propel its patented technology to a clinical development stage.

Valar Labs, a California-based TechMed startup that provides AI-powered computational histology AI (CHAI) tests designed to predict cancer therapies, has secured a $22M Series A funding to augment physicians’ capabilities.

LambdaVision, a Connecticut-based biotech company developing a protein-based artificial retina to help restore lost vision due to retinal degeneration diseases, has secured the first close of its seed round. According to the company’s announcement on Wednesday, May 29, 2024, the funding round was led by Aurelia Foundry Fund

Posterity Health, a male reproductive health-focused startup, has raised $6 million in the latest round to scale business operations and accelerate the development of its tech-backed care platform. As the company announced on Wednesday, May 29

Daffodil Health, a Bengaluru-based health tech startup that provides AI-powered healthcare administrative automation, announced it has secured $4.6 million in seed funding to advance the development of its software products. The funding round was spearheaded by Maverick Ventures, with a significant contribution from Epic Ventures. Daffodil Health was co-founded in 2018 by technology and healthcare Daffodil Health will use the funding to build an AI-powered healthcare administration and pricing platform.

TadHealth, a California-based health tech startup specializing in mental software as a service platform, has secured $1.6 million in a seed funding round to transform mental health services in schools. As announced by the company on May 23, 2024, the oversubscribed funding round was spearheaded by Halcyon Venture Partners, with significant contributions from USC Viterbi TadHealth will use the additional capital to enhance its product capabilities and expand its market presence across the United States.

Expressable announces its latest $26M Series B round of funding to revolutionize speech therapy with tech forward approach.

Abett, a Seattle-based startup that helps large employers manage and analyze health plan data, raised $11.6 million in a Series A round for its software platform.

Finnish startup Enifer looks to revive historic mycoprotein Pekilo with its latest 15M Series B round of funding.

Atropos Health, the pioneer of a smart clinical analytics platform designed to transform clinical data into high-quality, real-world evidence for healthcare, has secured a $33 million Series B funding to scale its performance.

A California-based medical device startup pioneering next-generation stroke technology has raised $5 million in seed funding to further develop and commercialize revolutionary technologies for safe cerebrovascular monitoring.

A San Francisco-based digital healthcare navigation company, Amino Health, has secured $10 Million in a funding round led by Transformational Capital to develop AI-powered personalized care journeys.

A San Francisco-based digital healthcare platform focusing on providing accessible, personalized preventive, and longevity-focused medicine, Superpower, has secured $4 million in pre-seed funding to extend personalized care to every household in America

Impulsonics, a medical device startup developing advanced acoustic wave-based cell technology, has secured £450,000 ( approximately $573,338) in early-stage funding, the University of Bristol announced on May 2, 2024.

SmarterDX, a New York-based provider of an automated pre-bill system designed to help hospitals and health systems prevent revenue leakages, has secured $50M in series B funding to advance its platform’s innovations and extend services to more customers across the United States. According to the startup’s announcement on May 14, 2024, the funding round was SmarterDX will use the new funding to scale and accelerate product innovation, benefiting more hospitals and health systems.